Application Software

Merlin

Merlin released FY2024 Annual Earnings on January 14, 2026 (EST), Actual Revenue: USD 1.229M, Actual EPS: USD -10.7953

Merlin released FY2023 Annual Earnings on January 14 (EST), actual revenue USD 1.003 M, actual EPS USD -8.1448

Merlin released FY2024 Q4 earnings on January 14 (EST), actual revenue USD 862K, actual EPS USD -2.6001

< 1B

1B - 5B

5B - 10B

10B - 50B

50B - 100B

100B - 500B

500B - 1T

≥ 1T

Market Value

Total Assets

< 100M

100M - 500M

500M - 1B

≥ 100B

Revenue

0 - 50M

50M - 100M

≥ 10B

Profits

< 0%

0% - 5%

5% - 10%

10 - 15%

15% - 20%

20 - 25%

25% - 30%

>= 30%

ROE(TTM)

= 0%

0% - 1%

1% - 3%

3% - 5%

5% - 8%

8% - 10%

>= 10%

Dividend Yield

0% - 10%

10% - 15%

20% - 30%

30% - 40%

40% - 50%

>= 50%

Net Profit Margin

0 - 0.05

0.05 - 0.1

0.1 - 0.2

0.2 - 0.4

0.4 - 0.6

0.6 - 0.8

0.8 - 1

>= 1

Asset Turnover

< 1.5

1.5 - 2

2 - 3

3 - 5

5 - 10

10 - 15

15 - 20

>= 20

Equity Multiplier

< 10%

10% - 30%

30% - 50%

50% - 70%

70 - 80%

80% - 90%

90% - 95%

>= 95%

Debt Ratio

Paranovus ENT Tech

Robin Energy - WI

AleAnna

ENvue Medical

Fundrise Innovation Fund LLC

CVD Equipment

T-REX 2X Inverse CRCL Daily Target ETF

MKD Tech

Sol-Gel Tech

Eagle Nuclear Energy

RDGT

ANNA

MRLN

Overview of the US Stock Market The current market shows a clear trend of differentiation, with technology stocks and the biopharmaceutical sector performing particularly well. Stocks with significant gains are mainly concentrated in innovative companies and emerging technology fields, with funds seemingly favoring high-growth stocks. Meanwhile, some traditional industries and small-cap stocks have faced considerable selling pressure, leading to increased overall volatility and a rise in short-term trading activity. The sharp decline of Ridgetech (down 90.50%) in the last hour has attracted widespread attention in the market, with trading volume significantly increasing and investor sentiment becoming tense. The stock's dramatic fluctuations appear to be related to recent financial issues, prompting a rapid withdrawal of funds. Strong stocks: 1. Fundrise Innovation Fund LLC: up 51.09%, with a six-month gain of 270.27%, continuously attracting capital inflows and boosting market sentiment. 2. AleAnna: up 46.65%, reaching a new 60-day high, with active short-term funds and optimistic market outlook. 3. Swarmer: up 44.15%, with increased trading volume indicating strong buying interest. 4. Sol-Gel Tech: up 41.24%, with a six-month gain of 215.83%, as investors are excited about its product line expansion. 5. YD Bio: up 34.67%, with significantly increased trading volume, as the market shows interest in its new drug development progress

Tracking Unusual Activity

Ridgetech

Swarmer

YD Bio

Yimutian

Novabay Pharmac

Quantum Biopharma

Southland

Hitek Global Inc.

Jianzhi Edu Tech

Ryde

Erayak Power Solution

ImmunityBio

U.S. Stock Market Movement Update: The U.S. stock market experienced significant volatility, with Ridgetech plummeting 90.50% and Fundrise Innovation Fund soaring 51.09%

Merlin rose 13.75%; Palantir Tech rose 5.98%, with a transaction volume of USD 6.151 billion; Strategy rose 0.99%, with a transaction volume of USD 1.903 billion; S&P 500 fell 0.25%, with a transaction volume of USD 1.546 billion; SAP rose 1.88%, with a market value of USD 209.1 billion

U.S. stock market midday update: Merlin rises 13.75% with increased trading volume, market sentiment is high but volatility raises concerns

GS-C

BACQ

GS-A

GS-D

FNCL

Goldman Sachs Group Inc, a major shareholder of Bleichroeder Acquisition Corp. I (NASDAQ:BACQ), sold 4,444 shares at an average price of $10.80, totaling $47,995.20. Post-sale, Goldman Sachs holds 3,285,714 shares valued at approximately $35.5 million, reflecting a 0.14% decrease in ownership. Recent transactions include additional sales and purchases of BACQ shares. The stock is currently trading at $10.52, with a 52-week range of $9.95 to $13.21. Analysts maintain a "sell" rating on BACQ shares, indicating cautious sentiment towards the stock.

Market Beat

GOLDMAN SACHS GROUP INC DEP SHS REPSTG 1/1000TH PRF SER C

Financial Select Sector SPDR Fund

Inflection Point Acquisition IV

GOLDMAN SACHS GROUP INC DEP SHR REP 1/1000TH PFD SER A

GOLDMAN SACHS GROUP INC DEP REP 1/1000TH PRF D

Fidelity MSCI Financials Index

VG Financial

Goldman Sachs

ISHRS Us Brokers & Sec Exchg

Bleichroeder Acquisition Corp. I (NASDAQ:BACQ) Major Shareholder Goldman Sachs Group Inc Sells 4,444 Shares

Merlin Labs, Inc. will host an Investor & Analyst Webinar on March 3, 2026, at 1:00 PM ET, featuring a presentation and Q&A with management. The company is set to become publicly traded through a business combination with Inflection Point Acquisition Corp. IV (Nasdaq: BACQ), announced on August 13, 2025. This transaction aims to enhance Merlin's capabilities in autonomous flight and strengthen its strategic acquisition pipeline, contributing to national security efforts. A recording of the webinar will be available on Merlin's website post-event.

StockTitan

Merlin Labs to Host Investor & Analyst Webinar on March 3, 2026 | BACQ Stock News

LB filings

Inflection Point Acquisition IV | 10-Q: FY2025 Q3 Revenue: USD 0

Bleichroeder Acquisition Corp (BACQ) shares are rising after Citron Research highlighted its favorable risk-reward profile. Citron claims BACQ could triple in value, emphasizing its merger partner, Merlin Labs, which has significant Pentagon contracts and a valuation of $800 million. The firm contrasts this with overvalued quantum computing stocks, suggesting BACQ offers downside protection with a net asset value floor at $10. BACQ shares are up 13.25% at $12.48, nearing a 52-week high.

Benzinga

What's Going On With Bleichroeder Acquisition Corp (BACQ) Stock Today?

Bleichroeder Acquisition Corp. I, now Inflection Point Acquisition Corp. IV, has received shareholder approval for a name change and amendments to its articles during an extraordinary general meeting on October 21, 2025. The amendments enable earlier redemption of public shares to support a proposed business combination, enhancing operational flexibility. The company has a current market cap of $377.1M and an average trading volume of 321,266, with a strong buy technical sentiment signal.

Tip Ranks

Inflection Point Acquisition Corp. IV Name Change Approved

Bleichroeder Acquisition II, a SPAC targeting technology, has filed with the SEC for a $250 million IPO, offering 25 million units at $10 each. Each unit includes one share of common stock and one-third of a warrant. Led by CEO Andrew Gundlach, the SPAC aims to invest in technology-driven companies, including those in AI and cloud computing. The company plans to list on Nasdaq under the symbol BBCQU, with Cohen & Company Securities as the bookrunner. Bleichroeder's previous SPAC raised $250 million in 2024 and is pending a merger with Merlin.

RenaissanceCapital

SPAC Bleichroeder Acquisition II files for a $250 million IPO, targeting technology

Bleichroeder Acquisition Corp. I (NASDAQ:BACQ) shares rose 1% to $10.81, with trading volume increasing by 318% to approximately 1.23 million shares. Despite the uptick, analysts maintain a consensus "Sell" rating, with Weiss Ratings reiterating this stance. Hedge funds have recently adjusted their stakes, with notable purchases from Meteora Capital LLC and Continental General Insurance Co. The company, a blank check firm, aims to engage in business combinations. Analysts suggest considering other stocks over BACQ for investment opportunities.

Bleichroeder Acquisition Corp. I (NASDAQ:BACQ) Stock Price Up 1%  - Here's What Happened

Bleichroeder Acquisition Corp. I (BACQ) announced a merger with Merlin Labs, a leader in autonomous flight technology, set to rename as Inflection Point Acquisition Corp. IV. Additionally, Merlin Labs partnered with GE Aerospace to develop AI solutions for military and civil aircraft, focusing on reducing crew requirements. This collaboration aims to enhance the aviation industry's approach to autonomous flight, leveraging both companies' expertise. Merlin Labs has secured over $100 million in military contracts and collaborates with major firms like Honeywell and Northrop Grumman.

GE Aerospace

Merlin Labs Partners with GE Aerospace for AI Solutions

DLD Asset Management LP has acquired a new stake in Bleichroeder Acquisition Corp. I (NASDAQ:BACQ), purchasing 124,673 shares valued at approximately $1.25 million. Other investors, including Mirae Asset Global Investments and Gritstone Asset Management, have also increased their stakes. Bleichroeder Acquisition Corp. I's stock opened at $10.39, with a recent upgrade to a "hold" rating by Wall Street Zen. The company, a blank check firm, aims to merge or acquire businesses.

DLD Asset Management LP Takes Position in Bleichroeder Acquisition Corp. I $BACQ

Merlin(MRLN.US)

Merlin Stock Performance Chart

Valuation analysis

Institutional View & Shareholder

Analyst Ratings

U.S. Stock Market Movement Update: The U.S. stock market experienced significant volatility, with Ridgetech plummeting 90.50% and Fundrise Innovation Fund soaring 51.09%

U.S. stock market midday update: Merlin rises 13.75% with increased trading volume, market sentiment is high but volatility raises concerns

Bleichroeder Acquisition Corp. I (NASDAQ:BACQ) Major Shareholder Goldman Sachs Group Inc Sells 4,444 Shares

Merlin Labs to Host Investor & Analyst Webinar on March 3, 2026 | BACQ Stock News

Inflection Point Acquisition IV | 10-Q: FY2025 Q3 Revenue: USD 0